RTTNews | Jul 13, 2021 07:39AM EDT

07:39 Tuesday, July 13, 2021 (RTTNews.com) - While reporting financial results for the fourth quarter on Tuesday, medical devices company AngioDynamics, Inc. (ANGO) initiated its adjusted earnings and net sales guidance for the full year 2022.

For fiscal 2022, the company now projects adjusted earnings in a range of flat to $0.05 per share on net sales between $305 million and $310 million.

On average, three analysts polled by Thomson Reuters expect the company to report earnings of $0.07 per share on net sales of $297.9 million for the year. Analysts' estimates typically exclude special items.

Read the original article on RTTNews ( https://www.rttnews.com/3208651/angiodynamics-guides-fy22-adj-eps-below-estimates-quick-facts.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved